Coronary artery bypass surgery pulmonary artery catheterization
Coronary Artery Bypass Surgery Microchapters | |
Pathophysiology | |
---|---|
Diagnosis | |
Treatment | |
Perioperative Monitoring | |
Surgical Procedure | |
Special Scenarios | |
Coronary artery bypass surgery pulmonary artery catheterization On the Web | |
FDA on Coronary artery bypass surgery pulmonary artery catheterization | |
CDC on Coronary artery bypass surgery pulmonary artery catheterization | |
Coronary artery bypass surgery pulmonary artery catheterization in the news | |
Blogs on Coronary artery bypass surgery pulmonary artery catheterization|- |
|
Directions to Hospitals Performing Coronary artery bypass surgery pulmonary artery catheterization | |
Risk calculators for Coronary artery bypass surgery pulmonary artery catheterization | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Varun Kumar, M.B.B.S. [2] Anahita Deylamsalehi, M.D.[3]
CABG Pulmonary Artery Catheterization
2021 ACA Revascularization Guideline [1][2][3][4][5]
High-risk Surgery | Highly selective use of pulmonary artery catheters may be safe for high-risk patients, such as elderies, or those with congestive heart failure, pulmonary hypertension, or numerous histories of valve procedures may be safe and may potentially help in the surveillance and treatment of hemodynamic instability. |
Isolated CABG | Use of pulmonary artery catheters is discouraged in low risk patients who are stable since there is no evidence of benefits or improvement in the outcome. |
2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery (DO NOT EDIT)[6]
Class I |
"1. Placement of a pulmonary artery catheter is indicated, preferably before the induction of anesthesia or surgical incision, in patients in cardiogenic shock undergoing CABG. (Level of Evidence: C)" |
Class IIa |
"1. Placement of a pulmonary artery catheter can be useful in the intraoperative or early postoperative period in patients with acute hemodynamic instability.[7][8][5][2][9] (Level of Evidence: B)" |
Class IIb |
"1. Placement of a pulmonary artery catheter may be reasonable in clinically stable patients undergoing CABG after consideration of baseline patient risk, the planned surgical procedure, and the practice setting.[7][8][5][2][9] (Level of Evidence: B)" |
Guidelines Resources
- 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery : A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines[6]
- 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.[10]
References
- ↑ Chiang Y, Hosseinian L, Rhee A, Itagaki S, Cavallaro P, Chikwe J (2015). "Questionable benefit of the pulmonary artery catheter after cardiac surgery in high-risk patients". J Cardiothorac Vasc Anesth. 29 (1): 76–81. doi:10.1053/j.jvca.2014.07.017. PMID 25620141.
- ↑ 2.0 2.1 2.2 Schwann TA, Zacharias A, Riordan CJ, Durham SJ, Engoren M, Habib RH (2002). "Safe, highly selective use of pulmonary artery catheters in coronary artery bypass grafting: an objective patient selection method". Ann Thorac Surg. 73 (5): 1394–401, discussion 1401-2. doi:10.1016/s0003-4975(02)03422-7. PMID 12022523.
- ↑ Schwann NM, Hillel Z, Hoeft A, Barash P, Möhnle P, Miao Y; et al. (2011). "Lack of effectiveness of the pulmonary artery catheter in cardiac surgery". Anesth Analg. 113 (5): 994–1002. doi:10.1213/ANE.0b013e31822c94a8. PMID 21918165.
- ↑ Ramsey SD, Saint S, Sullivan SD, Dey L, Kelley K, Bowdle A (2000). "Clinical and economic effects of pulmonary artery catheterization in nonemergent coronary artery bypass graft surgery". J Cardiothorac Vasc Anesth. 14 (2): 113–8. doi:10.1016/s1053-0770(00)90001-6. PMID 10794325.
- ↑ 5.0 5.1 5.2 Resano FG, Kapetanakis EI, Hill PC, Haile E, Corso PJ (2006). "Clinical outcomes of low-risk patients undergoing beating-heart surgery with or without pulmonary artery catheterization". J Cardiothorac Vasc Anesth. 20 (3): 300–6. doi:10.1053/j.jvca.2006.01.017. PMID 16750726.
- ↑ 6.0 6.1 Hillis LD, Smith PK, Anderson JL, Bittl JA, Bridges CR, Byrne JG; et al. (2011). "2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines". Circulation. doi:10.1161/CIR.0b013e31823c074e. PMID 22064599.
- ↑ 7.0 7.1 "Practice guidelines for pulmonary artery catheterization: an updated report by the American Society of Anesthesiologists Task Force on Pulmonary Artery Catheterization". Anesthesiology. 99 (4): 988–1014. 2003. PMID 14508336. Retrieved 2011-12-16. Unknown parameter
|month=
ignored (help) - ↑ 8.0 8.1 Pearson KS, Gomez MN, Moyers JR, Carter JG, Tinker JH (1989). "A cost/benefit analysis of randomized invasive monitoring for patients undergoing cardiac surgery". Anesthesia and Analgesia. 69 (3): 336–41. PMID 2505641. Retrieved 2011-12-16. Unknown parameter
|month=
ignored (help) - ↑ 9.0 9.1 Stewart RD, Psyhojos T, Lahey SJ, Levitsky S, Campos CT (1998). "Central venous catheter use in low-risk coronary artery bypass grafting". The Annals of Thoracic Surgery. 66 (4): 1306–11. PMID 9800825. Retrieved 2011-12-16. Unknown parameter
|month=
ignored (help) - ↑ Writing Committee Members. Lawton JS, Tamis-Holland JE, Bangalore S, Bates ER, Beckie TM; et al. (2022). "2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines". J Am Coll Cardiol. 79 (2): e21–e129. doi:10.1016/j.jacc.2021.09.006. PMID 34895950 Check
|pmid=
value (help).